Lukoon
Biopharmaceutical Companies Focus on Expanding Immuno Oncology Pipelines
The US Immuno-Oncology Drugs Market is expanding due to increasing cancer prevalence, advanced healthcare infrastructure, and strong investments in oncology research. Growing adoption of immunotherapy treatments is supporting the development of innovative cancer care solutions. Market Overview The Immuno-Oncology Drugs Market size was valued at US$ 77.80 billion in 2024 and is...
88 Views